Tax withholding trims Aurinia (AUPH) CFO stake by 32,424 shares
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Aurinia Pharmaceuticals Inc. Chief Financial Officer Joseph M. Miller reported a tax-related share disposition. On the vesting of restricted stock units, 32,424 shares of common stock were withheld at $14.40 per share to cover tax obligations, according to the footnote. After this withholding transaction, Miller directly owned 556,703 common shares.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Miller Joseph M
Role
Chief Financial Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Tax Withholding | Common Stock | 32,424 | $14.40 | $467K |
Holdings After Transaction:
Common Stock — 556,703 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Aurinia Pharmaceuticals (AUPH) report for its CFO?
Aurinia’s Chief Financial Officer Joseph M. Miller reported a tax-withholding disposition of 32,424 common shares. The shares were withheld upon vesting of restricted stock units to satisfy tax obligations, rather than sold on the open market.
Was the Aurinia (AUPH) CFO’s Form 4 transaction an open-market sale?
No, the transaction was not an open-market sale. The Form 4 describes a tax-withholding disposition, where 32,424 vested shares were withheld by the company to cover tax liabilities tied to restricted stock unit vesting.
What does transaction code "F" mean in the Aurinia (AUPH) Form 4 filing?
Transaction code “F” indicates a tax-withholding disposition. In this case, 32,424 vested shares of Aurinia common stock were withheld to pay exercise price or tax liabilities, rather than being bought or sold on the open market.